PDC and posterior cortical atrophy: Importantly, we provide evidence that KMT9-mediated control of PDC activity is not limited to PCa cell lines but is also a relevant mechanism in a well-established PCa mouse model29 as well as in human patients further underlining the therapeutic potential.